Cargando…

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

Establishing a definitive diagnosis of Cushing disease (CD), given its clinical and biochemical heterogeneity, initiating effective treatment to control the effects of hypercortisolism, and managing recurrence are challenging disease aspects to address. Mifepristone is a competitive glucocorticoid r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Alice Y, Mirfakhraee, Sasan, King, Elizabeth E, Mercado, Jennifer U, Donegan, Diane M, Yuen, Kevin CJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940725/ https://www.ncbi.nlm.nih.gov/pubmed/33746521 http://dx.doi.org/10.1177/1179551421994102

Ejemplares similares

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations
por: Brown, David R., et al.
Publicado: (2020)

THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)

Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
por: Sai, Katta, et al.
Publicado: (2019)

Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome
por: Díaz-Castro, Francisco, et al.
Publicado: (2020)

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome
por: Moraitis, Andreas G., et al.
Publicado: (2016)

Global clinical response in Cushing’s syndrome patients treated with mifepristone
por: Katznelson, Laurence, et al.
Publicado: (2014)

The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome
por: Rowell, Jennifer Voigt
Publicado: (2021)

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
por: Cohan, Pejman, et al.
Publicado: (2019)

MON-413 First Reported Case of Combined High-Dose Mifepristone Therapy and Oral Contraceptive in Inducing Reversible Cholestatic Hepatitis in a Patient with Cushing Disease
por: Youssef, Nancy, et al.
Publicado: (2019)

Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
por: Wallia, Amisha, et al.
Publicado: (2013)

SUN-186 Case Report: Mifepristone Taper in an Individual with Equivocal Cushing’s Syndrome Screening Tests
por: Martin, Christopher, et al.
Publicado: (2020)

PSAT041 A Rare Case of Severe Cyclical Cushing Syndrome Due to Ectopic ACTH Secretion by Appendiceal Carcinoid
por: Sidra, Fnu, et al.
Publicado: (2022)

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature
por: Ault, Taylor A., et al.
Publicado: (2023)

Resetting the Stress System with a Mifepristone Challenge
por: Dalm, Sergiu, et al.
Publicado: (2018)

Incidence of Venous Thromboembolic Events in Patients With Endogenous Cushing Syndrome
por: Subbu, Karthik, et al.
Publicado: (2021)

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
por: Yuen, Kevin C. J., et al.
Publicado: (2017)

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Sustained weight loss in patients treated with mifepristone for Cushing’s syndrome: a follow-up analysis of the SEISMIC study and long-term extension
por: Fein, Henry G., et al.
Publicado: (2015)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Mifepristone Increases Thyroid Hormone Requirements in Patients With Central Hypothyroidism: A Multicenter Study
por: Guarda, Francisco J, et al.
Publicado: (2019)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

Limited Efficacy of Mifepristone Due to Poor Tolerance: A Clinical Challenge in Managing Cortisol Excess
por: Mora Osoria, Gabriel Jose, et al.
Publicado: (2021)

Detecting post-surgical recurrence in a patient with Cushing’s disease
por: Moloney, Kelley J., et al.
Publicado: (2014)

X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor–Progesterone–Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface
por: Colucci, Jennifer K., et al.
Publicado: (2013)

A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease
por: Mirfakhraee, Sasan, et al.
Publicado: (2021)

Successful conservative management with methotrexate and mifepristone of cervical pregnancy
por: Shrestha, Eliza, et al.
Publicado: (2011)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome
por: Bancos, Irina, et al.
Publicado: (2021)

The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature
por: Cossu, Giulia, et al.
Publicado: (2015)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Clinical Utility of Mifepristone: Apprising the Expanding Horizons
por: Karena, Zalak V, et al.
Publicado: (2022)

SAT-117 Refractory Paraneoplastic Non Islet Cell Tumor Hypoglycemia (NICTH) from Hepatocellular Carcinoma Managed with Somatostatin Analogue and Glucocorticoids
por: Siddiqui, Mahwash Fatima, et al.
Publicado: (2020)

FRI242 Primary And Secondary Adrenal Insufficiency Post Transsphenoidal Surgery In Patient On Abiraterone Therapy
por: Akande, Rukayat Olabisi, et al.
Publicado: (2023)

A Pilot Study of Mifepristone in Combat-Related PTSD
por: Golier, Julia A., et al.
Publicado: (2012)

Mifepristone improves chemo-radiation response in glioblastoma xenografts
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_42opj9ua98j12b3saf6ce69enu